Is NEXGEL, INC. (NXGL) Halal?

NASDAQ Healthcare United States $5M
✗ NOT HALAL
Confidence: 90/100
NEXGEL, INC. (NXGL) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 30.2% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. NEXGEL, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 30.2%
/ 30%
19.3%
/ 30%
10.0%
/ 30%
1.98%
/ 5%
✗ NOT HALAL
DJIM 30.2%
/ 33%
19.3%
/ 33%
10.0%
/ 33%
1.98%
/ 5%
✓ HALAL
MSCI 25.7%
/ 33%
16.5%
/ 33%
8.5%
/ 33%
1.98%
/ 5%
✓ HALAL
S&P 30.2%
/ 33%
19.3%
/ 33%
10.0%
/ 33%
1.98%
/ 5%
✓ HALAL
FTSE 25.7%
/ 33%
16.5%
/ 33%
8.5%
/ 50%
1.98%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.37
P/B Ratio
1.0
EV/EBITDA
-3.2
EV: $8M
Revenue
$9M
Growth: -0.2%
Beta
0.6
Low volatility
Current Ratio
1.7

Profitability

Gross Margin 40.8%
Operating Margin -24.7%
Net Margin -24.7%
Return on Equity (ROE) -52.8%
Return on Assets (ROA) -16.8%

Cash Flow & Balance Sheet

Operating Cash Flow-$4M
Free Cash Flow-$4M
Total Debt$3M
Debt-to-Equity57.2
Current Ratio1.7
Total Assets$11M

Price & Trading

Last Close$0.70
50-Day MA$1.17
200-Day MA$1.97
Avg Volume263K
Beta0.6
52-Week Range
$0.65
$3.02

About NEXGEL, INC. (NXGL)

CEO
Mr. Adam R. Levy
Employees
19
Website
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$5M
Currency
USD

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is NEXGEL, INC. (NXGL) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), NEXGEL, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is NEXGEL, INC.'s debt ratio?

NEXGEL, INC.'s debt ratio is 30.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 25.7%.

What are NEXGEL, INC.'s key financial metrics?

NEXGEL, INC. has a market capitalization of $5M, and revenue of $9M. The company maintains a gross margin of 40.8% and a net margin of -24.7%. Return on equity stands at -52.8%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.